These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 8037711)
1. Inhibition of rat liver arginase by an intermediate in NO biosynthesis, NG-hydroxy-L-arginine: implications for the regulation of nitric oxide biosynthesis by arginase. Daghigh F; Fukuto JM; Ash DE Biochem Biophys Res Commun; 1994 Jul; 202(1):174-80. PubMed ID: 8037711 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of arginase by NG-hydroxy-L-arginine in alveolar macrophages: implications for the utilization of L-arginine for nitric oxide synthesis. Hecker M; Nematollahi H; Hey C; Busse R; Racké K FEBS Lett; 1995 Feb; 359(2-3):251-4. PubMed ID: 7532597 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of arginase in rat and rabbit alveolar macrophages by N omega-hydroxy-D,L-indospicine, effects on L-arginine utilization by nitric oxide synthase. Hey C; Boucher JL; Vadon-Le Goff S; Ketterer G; Wessler I; Racké K Br J Pharmacol; 1997 Jun; 121(3):395-400. PubMed ID: 9179379 [TBL] [Abstract][Full Text] [Related]
4. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat. Bagnost T; Berthelot A; Bouhaddi M; Laurant P; André C; Guillaume Y; Demougeot C J Hypertens; 2008 Jun; 26(6):1110-8. PubMed ID: 18475148 [TBL] [Abstract][Full Text] [Related]
5. N omega-hydroxyl-L-arginine, an intermediate in the L-arginine to nitric oxide pathway, is a strong inhibitor of liver and macrophage arginase. Boucher JL; Custot J; Vadon S; Delaforge M; Lepoivre M; Tenu JP; Yapo A; Mansuy D Biochem Biophys Res Commun; 1994 Sep; 203(3):1614-21. PubMed ID: 7945311 [TBL] [Abstract][Full Text] [Related]
6. Effect of nitric oxide synthase substrate analog inhibitors on rat liver arginase. Robertson CA; Green BG; Niedzwiecki L; Harrison RK; Grant SK Biochem Biophys Res Commun; 1993 Dec; 197(2):523-8. PubMed ID: 7505570 [TBL] [Abstract][Full Text] [Related]
7. Arginase activity in endothelial cells: inhibition by NG-hydroxy-L-arginine during high-output NO production. Buga GM; Singh R; Pervin S; Rogers NE; Schmitz DA; Jenkinson CP; Cederbaum SD; Ignarro LJ Am J Physiol; 1996 Nov; 271(5 Pt 2):H1988-98. PubMed ID: 8945918 [TBL] [Abstract][Full Text] [Related]
8. Modulation of cholinergic airway reactivity and nitric oxide production by endogenous arginase activity. Meurs H; Hamer MA; Pethe S; Vadon-Le Goff S; Boucher JL; Zaagsma J Br J Pharmacol; 2000 Aug; 130(8):1793-8. PubMed ID: 10952667 [TBL] [Abstract][Full Text] [Related]
9. Production of nitric oxide during graft rejection is regulated by the Th1/Th2 balance, the arginase activity, and L-arginine metabolism. Holán V; Pindjáková J; Krulová M; Neuwirth A; Fric J; Zajícová A Transplantation; 2006 Jun; 81(12):1708-15. PubMed ID: 16794538 [TBL] [Abstract][Full Text] [Related]
10. Comparison of substrate and inhibitor specificity of arginase and nitric oxide (NO) synthase for arginine analogues and related compounds in murine and rat macrophages. Hrabák A; Bajor T; Temesi A Biochem Biophys Res Commun; 1994 Jan; 198(1):206-12. PubMed ID: 7507318 [TBL] [Abstract][Full Text] [Related]
12. L-arginine binding to liver arginase requires proton transfer to gateway residue His141 and coordination of the guanidinium group to the dimanganese(II,II) center. Khangulov SV; Sossong TM; Ash DE; Dismukes GC Biochemistry; 1998 Jun; 37(23):8539-50. PubMed ID: 9622506 [TBL] [Abstract][Full Text] [Related]
13. Modulation of intrinsic cavernous tone and nitric oxide production by arginase in rabbit corpus cavernosum. Masuda H; Yano M; Sakai Y; Kihara K; Yamauchi Y; Azuma H J Urol; 2004 Jan; 171(1):490-4. PubMed ID: 14665961 [TBL] [Abstract][Full Text] [Related]
14. Distribution and properties of arginase in the salivary glands of four species of laboratory mammals. Yasuda N; Moriwaki K; Furuyama S J Comp Physiol B; 2004 Apr; 174(3):237-42. PubMed ID: 14712329 [TBL] [Abstract][Full Text] [Related]
15. N(delta)-Methylated L-arginine derivatives and their effects on the nitric oxide generating system. Kotthaus J; Schade D; Töpker-Lehmann K; Beitz E; Clement B Bioorg Med Chem; 2008 Mar; 16(5):2305-12. PubMed ID: 18083522 [TBL] [Abstract][Full Text] [Related]
16. Classical and slow-binding inhibitors of human type II arginase. Colleluori DM; Ash DE Biochemistry; 2001 Aug; 40(31):9356-62. PubMed ID: 11478904 [TBL] [Abstract][Full Text] [Related]
17. Interleukin 1beta-mediated inhibition of arginase in RINm5F cells. Cunningham JM; Mabley JG; Green IC Cytokine; 1997 Aug; 9(8):570-6. PubMed ID: 9245484 [TBL] [Abstract][Full Text] [Related]
18. Biochemical and functional profile of a newly developed potent and isozyme-selective arginase inhibitor. Baggio R; Emig FA; Christianson DW; Ash DE; Chakder S; Rattan S J Pharmacol Exp Ther; 1999 Sep; 290(3):1409-16. PubMed ID: 10454520 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of purified nitric oxide synthase from rat cerebellum and macrophage by L-arginine analogs. Komori Y; Wallace GC; Fukuto JM Arch Biochem Biophys; 1994 Dec; 315(2):213-8. PubMed ID: 7527206 [TBL] [Abstract][Full Text] [Related]
20. Liver I/R injury is improved by the arginase inhibitor, N(omega)-hydroxy-nor-L-arginine (nor-NOHA). Reid KM; Tsung A; Kaizu T; Jeyabalan G; Ikeda A; Shao L; Wu G; Murase N; Geller DA Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G512-7. PubMed ID: 17023552 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]